High clinical impact of rapid susceptibility testing on CHROMID ESBL® medium directly from swabs.

dc.contributor.authorRomo-Ibáñez, Álvaro
dc.contributor.authorCalatrava-Hernández, Elisabeth
dc.contributor.authorGutiérrez-Soto, Blanca
dc.contributor.authorPérez-Ruiz, Mercedes
dc.contributor.authorNavarro-Marí, José María
dc.contributor.authorGutiérrez-Fernández, José
dc.date.accessioned2025-01-07T14:23:33Z
dc.date.available2025-01-07T14:23:33Z
dc.date.issued2020
dc.description.abstractAntibiotic resistance is a serious public health challenge exacerbated by the widespread use of β-lactam and glycopeptide antibiotics. The identification of resistances is crucial, and CHROMID ESBL medium has been developed to detect enterobacteria with extended-spectrum β-lactamases (ESBL). The objective of this study was to evaluate the potential of this medium to detect other types of resistant bacteria. Vancomycin, cefoxitin, imipenem, and cefepime disks were used to measure growth on CHROMID ESBL medium of β-lactam-resistant Gram-negative (83 with ESBL, 57 with carbapenemases, 35 with AmpC and 3 Stenotrophomonas maltophilia) and Gram-positive [37 vancomycin-susceptible (vancoS) microorganisms and 21 vancomycin-resistant (vancoR) Enterococcus faecium] clinical isolates (retrospective study) and colonization by the aforementioned bacteria (prospective study), using 649 rectal swabs, 314 pharyngeal swabs, and 44 swabs from other localizations. Retrospective study: species grown on the medium exhibited different colors. Growth on the medium was observed for: all ESBL enterobacteria, which were susceptible to imipenem and cefoxitin; 95% of isolates with carbapenemases, mostly resistant to imipenem; 80% of those with AmpC; 86% of vancoR E. faecium isolates; and 42% of vancoS E. faecalis isolates, with large growth inhibition halos around the vancomycin disk. Prospective study: vancoR E. faecium, ESBL Klebsiella, Pseudomonas with carbapenemases, A. baumannii (mostly from rectal swabs), S. maltophilia, Achromobacter xylosoxidans, and Burkholderia cenocepacia (mostly from pharyngeal swabs) were isolated from the 246 positive samples. CHROMID ESBL medium permitted the differential growth of Gram-negative bacteria, many with ESBL and carbapenemases. ESBL enterobacteria were susceptible to imipenem, carbapenemase-producing microorganisms grew around the imipenem disk, and vancoR E. faecium was isolated on the medium. Results of the prospective study demonstrate the potential clinical relevance of this medium. S. maltophilia was more frequently detected with pharyngeal swabs and ESBL Klebsiella, A. baumannii, and Pseudomonas with rectal swabs.
dc.identifier.doi10.21037/atm.2020.02.158
dc.identifier.issn2305-5839
dc.identifier.pmcPMC7290529
dc.identifier.pmid32566630
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7290529/pdf
dc.identifier.unpaywallURLhttps://atm.amegroups.com/article/viewFile/38667/pdf
dc.identifier.urihttps://hdl.handle.net/10668/26346
dc.issue.number9
dc.journal.titleAnnals of translational medicine
dc.journal.titleabbreviationAnn Transl Med
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.page.number604
dc.pubmedtypeJournal Article
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCHROMID ESBL medium
dc.subjectMultiresistant bacteria
dc.subjectchromogenic media
dc.titleHigh clinical impact of rapid susceptibility testing on CHROMID ESBL® medium directly from swabs.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number8

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC7290529.pdf
Size:
590.43 KB
Format:
Adobe Portable Document Format